These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 25415868)
21. [Percutaneous radiofrequency ablation with artificial hydrothorax for liver cancer in the hepatic dome]. Han Y; Yu L; Hao YZ; Yang M; Liu S; Deng YB; He LF; Cai JQ; Chen MH Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):846-9. PubMed ID: 23291135 [TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation of subcapsular hepatocellular carcinoma: single center experience. Filippousis P; Sotiropoulou E; Manataki A; Konstantinopoulos O; Thanos L Eur J Radiol; 2011 Feb; 77(2):299-304. PubMed ID: 19733023 [TBL] [Abstract][Full Text] [Related]
32. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763 [TBL] [Abstract][Full Text] [Related]
33. Radiofrequency ablation for pulmonary metastases from esophageal squamous cell carcinoma. Baba Y; Watanabe M; Kawanaka K; Iwagami S; Ishimoto T; Iwatsuki M; Yoshida N; Yamashita Y; Baba H Dis Esophagus; 2014 Jan; 27(1):36-41. PubMed ID: 23384275 [TBL] [Abstract][Full Text] [Related]
34. Application of ultrasound-guided biopsy and percutaneous radiofrequency ablation in 2 cases with phosphaturic mesenchymal tumor and literature review. Xian MF; Pan KM; Zhang JC; Cheng MQ; Huang H; Chen LD; Zhao ZX; Wang W Clin Hemorheol Microcirc; 2021; 77(1):61-69. PubMed ID: 32924995 [TBL] [Abstract][Full Text] [Related]
35. Imaging-guided radiofrequency ablation of solid renal tumors. Farrell MA; Charboneau WJ; DiMarco DS; Chow GK; Zincke H; Callstrom MR; Lewis BD; Lee RA; Reading CC AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910 [TBL] [Abstract][Full Text] [Related]
36. Radiofrequency ablation of non-resectable lung tumors. Simanek V; Klecka J; Treska V; Ohlidalova K; Mirka H Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):451-4. PubMed ID: 23073536 [TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety. Rossi S; Viera FT; Ghittoni G; Cobianchi L; Rosa LL; Siciliani L; Bortolotto C; Veronese L; Vercelli A; Gallotti A; Ravetta V Pancreas; 2014 Aug; 43(6):938-45. PubMed ID: 24717825 [TBL] [Abstract][Full Text] [Related]
38. Laparoscopic ultrasound with radiofrequency ablation of hepatic tumors in cirrhotic patients. Salama IA; Korayem E; ElAbd O; El-Refaie A J Laparoendosc Adv Surg Tech A; 2010 Feb; 20(1):39-46. PubMed ID: 20100059 [TBL] [Abstract][Full Text] [Related]
39. Oncologic outcomes using real-time peripheral thermometry-guided radiofrequency ablation of small renal masses. Leveillee RJ; Castle SM; Gorbatiy V; Salas N; Narayanan G; Morillo-Burgos G; Jorda M; Faraday MM J Endourol; 2013 Apr; 27(4):480-9. PubMed ID: 23098088 [TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography. Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]